Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06601075
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
The Role of 18F-FDG and 68Ga-FAPI PETCT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer peritoneal Metastasis Withwithout Other Metastases
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Role of 18F-FDG and 68Ga-FAPI PETCT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer peritoneal Metastasis Withwithout Other Metastases
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the value of 18F-FDG and 68Ga-FAPI PETCT in evaluating the outcome of conversion therapy and the prognosis of advanced colorectal cancer peritoneal metastasis withwithout other metastases
Detailed Description:
The investigators will number all participants create a medical record file and record their basic information gender age as well as contact information and medical history information All participants will undergo 18F-FDG and 68Ga-FAPI PETCT at baseline and after 3 months of conversion therapy The imaging response measurements will be compared with the histopathological or clinical assessment results as gold standard
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None